WRIGHT; David Erick

Patent Applications and Registrations

Patent applications and USPTO patent grants for WRIGHT; David Erick.The latest application filed is for "methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy".

Company Profile

1.4.6

WRIGHT; David Erick - Ramona CA
Wright; David Erick - Romona CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Kits For Predicting Infusion Reaction Risk And Antibody-mediated Loss Of Response By Monitoring Serum Uric Acid During Pegylated Uricase Therapy App 20210181187 - ROSARIO-JANSEN; Theresa ; et al.	2021-06-17
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy Grant 10,823,727 - Rosario-Jansen , et al. November 3, 2	2020-11-03
Methods And Kits For Predicting Infusion Reaction Risk And Antibody-mediated Loss Of Response By Monitoring Serum Uric Acid Duri App 20190317083 - ROSARIO-JANSEN; Theresa ; et al.	2019-10-17
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy Grant 10,139,399 - Rosario-Jansen , et al. Nov	2018-11-27
Methods And Kits For Predicting Infusion Reaction Risk And Antibody-mediated Loss Of Response By Monitoring Serum Uric Acid During Pegylated Uricase Therapy App 20180188242 - ROSARIO-JANSEN; Theresa ; et al.	2018-07-05
Methods And Kits For Predicting Infusion Reaction Risk And Antibody-mediated Loss Of Response By Monitoring Serum Uric Acid During Pegylated Uricase Therapy App 20160377604 - Rosario-Jansen; Theresa ; et al.	2016-12-29
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy Grant 9,377,454 - Rosario-Jansen , et al. June 28, 2	2016-06-28
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy App 20120301454 - Rosario-Jansen; Theresa ; et al.	2012-11-29
Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase App 20080159976 - Hartman; Jacob ; et al.	2008-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.